 Shin Thant, one of the very first PrEP client in Myanmar, August 14, 2020 (credit: Shin Thant) On July 31st, 2020, with support from the USAID HIV/AIDS Flgship (UHF) Project, Myanmar launched its first Pre-Exposure Prophylaxis (PrEP) Program. PrEP is an HIV drug taken by HIV-negative people to protect them against HIV infection. If used consistently and correctly, PrEP virtually eliminates the risk of HIV infection. A number of large trials undertaken across the world have continued to prove PrEP’s effectiveness.
|
AuthorUSAID HIV/AIDS Flagship Project Archives
December 2020
Categories |
RSS Feed
